
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8830059
[patent_doc_number] => 20130131104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'HISTIDINE RICH PROTEIN-2 DIAGNOSTIC TEST FOR CEREBRAL MALARIA'
[patent_app_type] => utility
[patent_app_number] => 13/636435
[patent_app_country] => US
[patent_app_date] => 2011-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16473
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636435
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/636435 | HISTIDINE RICH PROTEIN-2 DIAGNOSTIC TEST FOR CEREBRAL MALARIA | Mar 21, 2011 | Abandoned |
Array
(
[id] => 8585718
[patent_doc_number] => 20130004539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'METHODS FOR PREVENTING AND TREATING STAPHYLOCOCCUS AUREUS COLONIZATION, INFECTION, AND DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/634184
[patent_app_country] => US
[patent_app_date] => 2011-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 11042
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634184
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/634184 | METHODS FOR PREVENTING AND TREATING STAPHYLOCOCCUS AUREUS COLONIZATION, INFECTION, AND DISEASE | Mar 13, 2011 | Abandoned |
Array
(
[id] => 6016380
[patent_doc_number] => 20110224097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'VIABLE GRAM NEGATIVE BACTERIA LACKING OUTER MEMBRANE AGONISTS OF TLR4/MD-2'
[patent_app_type] => utility
[patent_app_number] => 13/046562
[patent_app_country] => US
[patent_app_date] => 2011-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 105
[patent_figures_cnt] => 105
[patent_no_of_words] => 21635
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224097.pdf
[firstpage_image] =>[orig_patent_app_number] => 13046562
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/046562 | Viable gram negative bacteria lacking outer membrane agonists of TLR4/MD-2 | Mar 10, 2011 | Issued |
Array
(
[id] => 8566088
[patent_doc_number] => 20120328659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'TREATMENT OF STREPTOCOCCAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/581940
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17300
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581940
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/581940 | TREATMENT OF STREPTOCOCCAL INFECTIONS | Mar 7, 2011 | Abandoned |
Array
(
[id] => 6014876
[patent_doc_number] => 20110223174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'Nontypeable Haemophilus Influenzae Virulence Factors'
[patent_app_type] => utility
[patent_app_number] => 13/042150
[patent_app_country] => US
[patent_app_date] => 2011-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13578
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223174.pdf
[firstpage_image] =>[orig_patent_app_number] => 13042150
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/042150 | Nontypeable Haemophilus Influenzae Virulence Factors | Mar 6, 2011 | Abandoned |
Array
(
[id] => 8989287
[patent_doc_number] => 20130216568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'IMMUNOGENIC PROTEINS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/580724
[patent_app_country] => US
[patent_app_date] => 2011-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28321
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580724
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/580724 | IMMUNOGENIC PROTEINS AND COMPOSITIONS | Feb 27, 2011 | Abandoned |
Array
(
[id] => 9019929
[patent_doc_number] => 08529912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof'
[patent_app_type] => utility
[patent_app_number] => 13/030660
[patent_app_country] => US
[patent_app_date] => 2011-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 36475
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13030660
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/030660 | Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof | Feb 17, 2011 | Issued |
Array
(
[id] => 7976731
[patent_doc_number] => 08071112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Compositions and methods of use of ORF-1358 from beta-hemolytic streptococcal strains'
[patent_app_type] => utility
[patent_app_number] => 13/028734
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20784
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071112.pdf
[firstpage_image] =>[orig_patent_app_number] => 13028734
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/028734 | Compositions and methods of use of ORF-1358 from beta-hemolytic streptococcal strains | Feb 15, 2011 | Issued |
Array
(
[id] => 9134385
[patent_doc_number] => 20130295099
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2013-11-07
[patent_title] => 'N-LINKEDGLYCAN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/578445
[patent_app_country] => US
[patent_app_date] => 2011-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 5871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/578445 | N-linked glycan compounds | Feb 10, 2011 | Issued |
Array
(
[id] => 9134385
[patent_doc_number] => 20130295099
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2013-11-07
[patent_title] => 'N-LINKEDGLYCAN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/578445
[patent_app_country] => US
[patent_app_date] => 2011-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 5871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/578445 | N-linked glycan compounds | Feb 10, 2011 | Issued |
Array
(
[id] => 9134385
[patent_doc_number] => 20130295099
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2013-11-07
[patent_title] => 'N-LINKEDGLYCAN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/578445
[patent_app_country] => US
[patent_app_date] => 2011-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 5871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/578445 | N-linked glycan compounds | Feb 10, 2011 | Issued |
Array
(
[id] => 8509189
[patent_doc_number] => 20120308597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'SEROLOGIC CORRELATES OF PROTECTION AGAINST BACILLIS ANTHRACIS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/577878
[patent_app_country] => US
[patent_app_date] => 2011-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13461
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577878
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/577878 | Serologic correlates of protection against Bacillis anthracis infection | Feb 9, 2011 | Issued |
Array
(
[id] => 10013064
[patent_doc_number] => 09056068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'Vaccine and methods of use against Strongyloide stercoralis infection'
[patent_app_type] => utility
[patent_app_number] => 13/575987
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 7794
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575987
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575987 | Vaccine and methods of use against Strongyloide stercoralis infection | Jan 31, 2011 | Issued |
Array
(
[id] => 6142256
[patent_doc_number] => 20110129502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Immunogenic Constructs'
[patent_app_type] => utility
[patent_app_number] => 13/007062
[patent_app_country] => US
[patent_app_date] => 2011-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19562
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129502.pdf
[firstpage_image] =>[orig_patent_app_number] => 13007062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/007062 | Immunogenic constructs | Jan 13, 2011 | Issued |
Array
(
[id] => 7518510
[patent_doc_number] => 07972611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Fungus-induced inflammation and eosinophil degranulation'
[patent_app_type] => utility
[patent_app_number] => 12/973100
[patent_app_country] => US
[patent_app_date] => 2010-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 57
[patent_no_of_words] => 15857
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/972/07972611.pdf
[firstpage_image] =>[orig_patent_app_number] => 12973100
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/973100 | Fungus-induced inflammation and eosinophil degranulation | Dec 19, 2010 | Issued |
Array
(
[id] => 7711445
[patent_doc_number] => 08092812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Methods and compositions for immunization against chlamydial infection and disease'
[patent_app_type] => utility
[patent_app_number] => 12/971729
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33955
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/092/08092812.pdf
[firstpage_image] =>[orig_patent_app_number] => 12971729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/971729 | Methods and compositions for immunization against chlamydial infection and disease | Dec 16, 2010 | Issued |
Array
(
[id] => 5944764
[patent_doc_number] => 20110105384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'USE OF POLYPEPTIDES HAVING ANTIMICROBIAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/969962
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17317
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105384.pdf
[firstpage_image] =>[orig_patent_app_number] => 12969962
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/969962 | Use of polypeptides having antimicrobial activity | Dec 15, 2010 | Issued |
Array
(
[id] => 10898314
[patent_doc_number] => 08921529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Therapies for preventing or suppressing Clostridium difficile infection'
[patent_app_type] => utility
[patent_app_number] => 13/513555
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 19723
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513555
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/513555 | Therapies for preventing or suppressing Clostridium difficile infection | Dec 5, 2010 | Issued |
Array
(
[id] => 8612249
[patent_doc_number] => 20130017561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Lateral Flow Device for Diagnosing Microbial Infections'
[patent_app_type] => utility
[patent_app_number] => 13/511264
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23132
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511264
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511264 | Lateral flow device for diagnosing microbial infections | Nov 22, 2010 | Issued |
Array
(
[id] => 6212855
[patent_doc_number] => 20110136155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'PEPTIDES AND METHODS FOR THE DETECTION OF LYME DISEASE ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/948209
[patent_app_country] => US
[patent_app_date] => 2010-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19191
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136155.pdf
[firstpage_image] =>[orig_patent_app_number] => 12948209
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/948209 | Peptides and methods for the detection of Lyme disease antibodies | Nov 16, 2010 | Issued |